Hsi-Ming Lee

Title: Hsi-Ming Lee: Innovator in Medical Science

Introduction

Hsi-Ming Lee is a notable inventor based in Setauket, NY (US), recognized for his contributions to medical science through innovative patents. With a total of six patents to his name, he has made significant strides in the fields of cholesterol management and cancer treatment.

Latest Patents

Among his latest patents is a method for decreasing low-density lipoprotein (LDL) cholesterol levels in mammals. This invention involves administering an effective amount of a tetracycline formulation, which can be either a non-antibacterial or an antibacterial tetracycline at a sub-antibacterial amount. Another significant patent is a method of inhibiting cancer growth, specifically targeting sarcomas such as Kaposi's sarcoma, utilizing 6-demethyl-6-deoxy-4-de(dimethylamino)tetracycline (CMT-3).

Career Highlights

Hsi-Ming Lee has had a distinguished career, working at prominent institutions such as the State University of New York and the University of Miami. His work has focused on developing innovative solutions to pressing health issues, particularly in the areas of cholesterol management and cancer treatment.

Collaborations

Throughout his career, Hsi-Ming Lee has collaborated with esteemed colleagues, including Lorne M Golub and Thomas F McNamara. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hsi-Ming Lee's innovative work in medical science has led to significant advancements in the treatment of cholesterol-related conditions and cancer. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.